TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 0 | 3 | -5 | 5 | -25 | -72 | -19 |
| P | %wins | 33 | 33 | 33 | 100 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/13/10 11:30 | 9/9/10 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | P | 165 | 5.50 | 0 | 30 | 1 | 2,648 | D | 77 | -28 | -28 | -27 | -22 | -1 | -4 | -4 | 6 | 15 | 23 | 10 | -36 | -70 |
7/29/10 11:12 | 1/25/10 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | P.m | 1,172 | 7.23 | 0 | 162 | 5 | 3,305 | M | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
7/29/10 11:09 | 9/11/09 | NGSX | Neurogesx Inc | CA | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | P.m | 11,440 | 7.92 | 0 | 1,445 | 85 | 3,143 | M | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |